Meda is one of the leading European pharmaceutical groups. Net sales break down by source of income as follows:
- sales of drugs (94.5%): intended for treating cardiologic, dermatologic, respiratory, gastro-enterologic, and inflammatory diseases;
- sales of manufacturing services (2.1%);
- other (3.4%): sales of research and development services and sales of licenses.
Net sales are distributed geographically as follows: Europe (70.6%), the United States (20.1%) and other (9.3%).